Cefazolin Inoculum Effect and MSSA Bacteremia: A Rapid Test to Guide Therapy
Official title: Clinical Impact of the Cefazolin Inoculum Effect
Funded at Methodist Hospital Research Institute · NIH-11552821 · Data updated 2026-11-12
A study to understand how a high bacterial load affects cefazolin treatment for serious Staphylococcus aureus infections and to test a quick lab method that helps doctors choose the best antibiotic.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | June 1, 2025 |
| Project end | May 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $161,779 |
| NIH project number | 3R01AI173138-04S2 |
| Project ID | NIH-11552821 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with MSSA bacteremia treated in hospital settings, and laboratories that process blood culture results.
✕Less likely to help
If a patient does not have MSSA bacteremia or if rapid CzIE testing is not available at their hospital, direct benefit may be limited.
What this research studies
This project investigates how the cefazolin inoculum effect may impact outcomes in patients with MSSA bacteremia and aims to implement a fast nitrocefin-based test in routine clinical labs. The team will explore whether rapid detection of CzIE can identify patients at higher risk of poor outcomes and inform antibiotic choices. It includes an international collaboration to ensure the findings apply across different healthcare settings. The study focuses on translating lab findings into practical guidance for clinicians treating severe MSSA infections.
Why it matters
Potential benefit: If successful, clinicians could quickly identify patients at risk for treatment failure and tailor antibiotic therapy to improve recovery and reduce adverse effects.
How similar studies have gone: Previous work suggests CzIE relates to treatment outcomes, but rapid, routine detection in clinical labs is novel and promising.
Where this research is happening
-
Methodist Hospital Research Institute
Houston, United States Active
Researchers
- Principal investigator: Arias, Cesar Augusto — Methodist Hospital Research Institute
- Study coordinator: Arias, Cesar Augusto
Related research
Other NIH-funded projects on the same topics.
-
Investigating how DNA damage and repair mechanisms are altered in ALS and frontotemporal dementia.
This study is looking at how problems with DNA repair might contribute to conditions like ALS and frontotemporal dementia, and it’s testing ways to fix these issues in cells from patients to help develop new treatments.
-
Cefazolin Inoculum Effect: How this test could improve care for MSSA bloodstream infections
This project tests a quick lab test to find a specific cefazolin resistance pattern in MSSA blood infections so doctors can choose safer, more effective treatment.
-
Vascularized niche with local immune protection to transplant insulin-producing cells for Type 1 diabetes
A new approach aims to transplant insulin-producing cells inside a vascularized pocket with local drug delivery to keep them alive and functioning without full-body immune suppression.
-
How brain connections guide visual choices in ADHD
A research study aims to understand how specific brain pathways help people with ADHD make visual decisions, using non-invasive methods in primates.
-
Why some Klebsiella pneumoniae infections resist key carbapenem antibiotics
This project looks at why certain Klebsiella pneumoniae infections resist carbapenem antibiotics and how those infections affect adult patients.
-
Targeting mitochondrial DNA repair defects in FUS-ALS with neuron-specific DNA Ligase I therapy
A patient-facing study aims to test a neuron-directed therapy that helps nerve cells repair their mitochondrial DNA in people with ALS linked to FUS mutations.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.